# Evaluating the Safety and Efficacy of Decitabine in the Treatment of XMEN Patients

> **NCT07555405** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Children's Hospital of Fudan University** · enrollment: 6 (estimated)

## Conditions studied

- MAGT1 Deficiency

## Interventions

- **DRUG:** Decitabine

## Key facts

- **NCT ID:** NCT07555405
- **Lead sponsor:** Children's Hospital of Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04
- **Primary completion:** 2028-12
- **Final completion:** 2028-12
- **Target enrollment:** 6 (ESTIMATED)
- **Last updated:** 2026-04-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07555405

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07555405, "Evaluating the Safety and Efficacy of Decitabine in the Treatment of XMEN Patients". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07555405. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*